BEQALZI

Advertisement

cGxPJobs Banner

BeOne Sets New CLL Benchmark with 78-Month BRUKINSA Data at ASCO 2026

SAN CARLOS, Calif. | May 29, 2026 BeOne Medicines presented groundbreaking long-term data at the 2026 American Society of...

By cGxPwire Editor
June 1, 2026

Read More

BeOne Medicines Wins FDA Approval for BEQALZI in Mantle Cell Lymphoma

SAN CARLOS, Calif., May 13, 2026 BeOne Medicines announced that the U.S. Food and Drug Administration (FDA) has granted...

By cGxPwire Editor
May 14, 2026

Read More

Advertisement

cGxPJobs

Directory